|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 14, 2017 ) Increase in prevalence of cancer across the globe and favourable government policies are the factors fuelling the market growth. Whereas factors like lack of skilled professionals is restraining the market. Oncology segment is anticipated to grow at higher CAGR during forecast period owing to the expirations of existing patent. North America accounted for the highest market share as compared to other regions owing to favourable government policies. Asia pacific region is expected to show healthy growth rate during forecast period.
For more information about this report: http://www.reportsweb.com/specialty-generics-global-market-outlook-2016-2022
Some of the key players in the market include Valeant Pharmaceuticals International, Inc., Novartis, Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V., Akorn, Inc., Mallinckrodt, Intellipharmaceutics and Alvogen.
Route of Administration Covered:
-Topical
-Parenteral
-Oral
-Other Route of Administration
Disease Indications Covered:
-Multiple Sclerosis
-Infectious diseases
-Oncology
-Other Disease Indications
Distribution Channels Covered:
-Mail Order Pharmacies
-Hospital Pharmacies
-Retail Pharmacies
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716566/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
10.1 Valeant Pharmaceuticals International, Inc.
10.2 Novartis
10.3 Pfizer Inc.
10.4 Turing Pharmaceuticals
10.5 Teva Pharmaceutical Ltd.
10.6 Mylan N.V.
10.7 Akorn, Inc.
10.8 Mallinckrodt
10.9 Intellipharmaceutics
10.10 Alvogen
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716566/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
